RecruitingPhase 1NCT06112093

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study


Sponsor

State University of New York - Upstate Medical University

Enrollment

60 participants

Start Date

Oct 23, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Repetitive Transcranial Magnetic Stimulation and a medical device called Sham Repetitive Transcranial Magnetic Stimulation for people with brain concussion, headache, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

rTMS will be used to regulate the motor cortex to reduce headaches and post-concussion symptoms.

DEVICESham Repetitive Transcranial Magnetic Stimulation

Sham rTMS will be delivered by a sham coil as a comparator to the (active) rTMS. Sham rTMS will not change the brain function of the control group.


Locations(1)

SUNY Upstate Medical University

Syracuse, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06112093


Related Trials